Cardiometabolic and Lipids Strategies for Primary Care-Triglyceride as a Factor in Residual CVD Risk

Video Transcription

Video Summary

In this video, Dr. Elliott Brinton discusses the topic of high triglycerides and its association with cardiovascular disease. He explains that high triglyceride levels increase the risk of pancreatitis and atherosclerosis. Dr. Brinton emphasizes the importance of treating high triglycerides in individuals with low-density lipoprotein (LDL) cholesterol levels in the normal range, as there is evidence to suggest that atherosclerosis risk may be related to triglyceride levels below the traditional cutoff of 200. He introduces icosapent ethyl (IPE) as an effective treatment option for lowering both triglycerides and reducing cardiovascular risk, based on the results of the REDUCE-IT trial. Dr. Brinton also discusses the use of other medications, such as fibrates and niacin, but notes that the evidence supporting their efficacy is not as strong. He covers the benefits and challenges of measuring triglyceride levels and emphasizes the importance of individualized treatment based on a patient's risk profile. Overall, the video provides a comprehensive overview of the relationship between high triglycerides and cardiovascular disease and highlights the potential role of IPE in managing this risk.

Keywords

high triglycerides

cardiovascular disease

pancreatitis

atherosclerosis

LDL cholesterol levels

icosapent ethyl

REDUCE-IT trial

fibrates

niacin